And the Nobel prize for vision award goes to?

Article

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

The $1.3 million award, the largest of its kind in ophthalmology will be shared between J Anthony Movshon, director of New York University’s Centre for Neural Science and William T. Newsome, a neuroscientist at Stanford University.

For over three decades both scientists have worked jointly and separately on the way our brains process visual information, supporting our perception. Leonor Beleza, president of The Champalimaud Foundation, said: “Visual perception starts with the eyes, but it happens in the brain. Over a 30-year period, the work of Movshon and Newsome has taken this axiom to new scientific levels of understanding. Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world. Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception. We are very proud to recognize Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award.”

According to www.healthnewsdigest.com William Newsome heard about the award following a weekly lab meeting when he listened to his mobile phone messages: “There was a message from my wife telling me an ophthalmologist in Portugal had called and told her he was absolutely sure I would really, really want to call him back.” The ophthalmologist turned out to be a member of the Champalimaud jury panel: Alfred Summer, MD, dean of the School of Hygiene and Public Health and professor of ophthalmology, epidemiology and international health at Johns Hopkins University.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.